Physician profile
Michael K Brosman
NPI 1720032832
$4,588.12
in general payments reported to CMS, 2019-2025
30 companies · $949 in 2025
The $949 reported for 2025 was more than what 76% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $379 · 2020: $229 · 2021: $480 · 2022: $836 · 2023: $710 · 2024: $1,005 · 2025: $949.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,642 · Long Term Medical Supply Or Device Loan: $21.86.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,642.42 |
| Long Term Medical Supply Or Device Loan | $21.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $668.57 | 2019-2025 | Cequa |
| Bausch & Lomb Americas INC. | $637.00 | 2022-2025 | Miebo, Xiidra, Vyzulta |
| Novartis Pharmaceuticals Corporation | $515.26 | 2019-2023 | |
| Alcon Vision LLC | $483.04 | 2020-2025 | Tryptyr, Precision7, Clareon |
| Regeneron Healthcare Solutions, INC. | $470.26 | 2020-2025 | Eylea Hd, Eylea |
| Tarsus Pharmaceuticals, INC. | $253.80 | 2024-2025 | Xdemvy |
| Abbvie INC. | $146.20 | 2022-2025 | Lumigan, Alphagan P, Vuity |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $135.55 | 2019-2021 | |
| Biotissue Holdings INC. | $125.83 | 2019-2025 | |
| Mallinckrodt Hospital Products INC. | $111.58 | 2022 | |
| Aerie Pharmaceuticals, INC. | $111.29 | 2019-2021 | |
| Oyster Point Pharma, INC. | $103.30 | 2022-2024 | Tyrvaya |
| Kala Pharmaceuticals, INC. | $102.56 | 2019-2022 | |
| Johnson & Johnson Vision Care, INC. | $81.05 | 2019-2023 | Acuvue |
| Amgen INC. | $75.68 | 2024-2025 | Tepezza |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $72.25 | 2021-2022 | |
| Johnson & Johnson Surgical Vision, INC. | $71.23 | 2021-2023 | Tecnis Iol, Tecnis Simplicity |
| Allergan, INC. | $60.27 | 2021-2022 | |
| Rxsight INC | $49.80 | 2023-2025 | Rxsight Contact Lens, Rxsight Injector Cartridge, Rxsight Injector Handpiece |
| Sight Sciences, INC. | $47.68 | 2023 | Tearcare System |
| Carl Zeiss Meditec USA, INC. | $39.50 | 2023 | Lumera 700 |
| Carl Zeiss Meditec Ag | $38.80 | 2020 | |
| Dompe US, INC. | $33.44 | 2024 | Oxervate |
| Astellas Pharma US INC | $32.13 | 2025 | Izervay |
| Harrow Eye, LLC | $28.27 | 2024 | Vevye |
| Coopervision INC. | $24.93 | 2019 | |
| Genentech USA, INC. | $20.93 | 2019 | |
| New World Medical,INC. | $17.92 | 2021 | |
| Thea Pharma INC. | $15.11 | 2024 | Iyuzeh |
| Ocular Therapeutix, INC. | $14.89 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Brosman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.